As CEACAM6 has universal oncogenic features, it has been reported as a relevant prognostic biomarker in other malignancies: cholangiocarcinoma, osteosarcoma, renal cancer, colorectal cancer, gastric cancer [39,40,41,42,43,44,45]. This evidence concerns the gene CEACAM6 and renal carcinoma.